+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Dementia Drugs Market 2020-2026

  • ID: 5129806
  • Report
  • June 2020
  • Region: Global
  • Orion Market Research Private Limited
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbvie Inc.
  • Aurobindo Pharma Ltd.
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Co.
  • Impax Laboratories, Inc.
  • Mylan NV
  • MORE
Global Dementia Drugs Market Size, Share & Trends Analysis Report By Type of Dementia (Lewy Body Dementia, Parkinson’s Disease, Alzheimer's Disease, and Others), By Type of Drug (Cholinesterase Inhibitors, MAO Inhibitors, Glutamate Inhibitors, and Others), and Forecast 2020-2026
The global dementia drugs market is anticipated to grow at a significant CAGR during the forecast period. Dementia is a group of condition that results in impairment of the brain’s at least two functions. The most common impaired brain functions in dementia include loss of judgment as well as memory. The major factor contributing to the growth of the market includes the increasing geriatric population across the globe as they are more prone to dementia and its related conditions such as Alzheimer's and Parkinson's.

The global dementia drugs market is segmented on the basis of the type of dementia and type of drugs. Based on the type of dementia, the market is sub-segmented into Lewy body dementia, Parkinson's disease dementia, Alzheimer's disease dementia, and others such as vascular dementia. Alzheimer’s disease segment is expected to exhibit a lucrative growth during the forecast period. Further based on the type of drugs, the market is sub-segmented into cholinesterase inhibitors, MAO inhibitors, Glutamate inhibitors, and others.

The global dementia drugs market is further segmented based on geography into North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to hold a significant share in the market during the forecast period. The growth in the region is due to the well-developed healthcare sector engaged in providing its elderly population with better healthcare facilities for the conditions such as Parkinson’s disease and Alzheimer disease. Asia-Pacific is estimated to exhibit a significant growth rate in the global cluster headache market during the forecast period. The increasing geriatric population in the region drives the growth of the market. In addition, improving healthcare infrastructure further gives a boost to the regional growth of the market.

Moreover, the study of the global dementia drugs market report covers the analysis of various players operating in the market. Some of the key players operating in the global dementia drugs market include Boehringer Ingelheim GmbH, Teva Pharmaceuticals Industries Ltd., Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline Plc, Aurobindo Pharma Ltd., Biogen Inc., and others.

Research Methodology

The market study of the global dementia drugs market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report is intended for the pharmaceutical industry, drug manufacturers, hospitals& clinics, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the companies, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Dementia Drugs Market Research and Analysis by Type of Dementia
2. Global Dementia Drugs Market Research and Analysis by Type of Drug

The Report Covers
  • Comprehensive research methodology of the global dementia drugs market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global dementia drugs market.
  • Insights about market determinants which are stimulating the global dementia drugs market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbvie Inc.
  • Aurobindo Pharma Ltd.
  • Boehringer Ingelheim GmbH
  • Eli Lilly and Co.
  • Impax Laboratories, Inc.
  • Mylan NV
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Key Strategy Analysis
3.2. Key Company Analysis
3.2.1. Boehringer Ingelheim GmbH
3.2.1.1. Overview
3.2.1.2. Financial Analysis
3.2.1.3. SWOT Analysis
3.2.1.4. Recent Developments
3.2.2. Teva Pharmaceuticals Industries Ltd.
3.2.2.1. Overview
3.2.2.2. Financial Analysis
3.2.2.3. SWOT Analysis
3.2.2.4. Recent Developments
3.2.3. Merck & Co. Inc.
3.2.3.1. Overview
3.2.3.2. Financial Analysis
3.2.3.3. SWOT Analysis
3.2.3.4. Recent Developments
3.2.4. Pfizer Inc.
3.2.4.1. Overview
3.2.4.2. Financial Analysis
3.2.4.3. SWOT Analysis
3.2.4.4. Recent Developments
3.2.5. GlaxoSmithKline Plc
3.2.5.1. Overview
3.2.5.2. Financial Analysis
3.2.5.3. SWOT Analysis
3.2.5.4. Recent Developments

4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities

5. Market Segmentation
5.1. Global Dementia Drugs Market by Type of Dementia
5.1.1. Lewy Body Dementia
5.1.2. Parkinson’s Disease Dementia
5.1.3. Alzheimer's Disease Dementia
5.1.4. Others
5.2. Global DementiaDrugsMarket by Type of Drugs
5.2.1. Cholinesterase Inhibitors
5.2.2. MAO Inhibitors
5.2.3. GlutamateInhibitors
5.2.4. Others

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbvie Inc.
7.2. ACADIA Pharmaceuticals Inc.
7.3. Apotex Corp.
7.4. Aurobindo Pharma Ltd.
7.5. Biogen Inc.
7.6. Boehringer Ingelheim GmbH
7.7. Eisai Co., Ltd.
7.8. Eli Lilly and Co.
7.9. GlaxoSmithKline Plc
7.10. Impax Laboratories, Inc.
7.11. Johnson & Johnson Services, Inc.
7.12. Merck & Co. Inc.
7.13. Mylan NV
7.14. Novartis International AG
7.15. Pfizer Inc.
7.16. Teva Pharmaceutical Industries Ltd.
7.17. Vertical Pharmaceuticals, LLC
7.18. Zydus Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
3 of 3
  • Abbvie Inc.
  • ACADIA Pharmaceuticals Inc.
  • Apotex Corp.
  • Aurobindo Pharma Ltd.
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Eisai Co., Ltd.
  • Eli Lilly and Co.
  • GlaxoSmithKline Plc
  • Impax Laboratories, Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Vertical Pharmaceuticals, LLC
  • Zydus Pharmaceuticals, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll